Site icon One Health Breakthrough Partnership

New Cross-Government Group to Tackle Pharmaceutical Pollution

The UK government has announced the creation of a new cross-government group to tackle the issue of pharmaceutical pollution. The Pharmaceuticals in the Environment (PiE) group will bring together representatives from the Environment Agency, the Department for Environment, Food and Rural Affairs, the Health and Safety Executive, the Medicines and Healthcare products Regulatory Agency, the Veterinary Medicines Directorate, and the Veterinary Products Committee.

The group will be tasked with developing a strategy to reduce the levels of pharmaceuticals entering the environment. This will include identifying sources of pollution, assessing the risks to human health and the environment, and developing measures to reduce emissions.

OHBP steering group members from NHS Highland (Prof Sharon Pfleger) and the Scottish Environment Protection Agency will join this new group to direct and support activities across the devolved nations in Scotland.

What are the risks of pharmaceutical pollution?

Pharmaceuticals can enter the environment through a variety of sources, including:

Once in the environment, pharmaceuticals can have a number of negative impacts, including:

What can be done to reduce pharmaceutical pollution?

There are a number of things that can be done to reduce pharmaceutical pollution, including:

The new cross-government group is a positive step towards tackling this important issue. By working together, government agencies and other stakeholders can make a real difference in reducing the levels of pharmaceuticals entering the environment.

Exit mobile version